|
EconStor >
Max-Planck-Institut für Ökonomik, Jena >
Jena Economic Research Papers, MPI für Ökonomik >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10419/31772
|
| | |
| Title: | | Technological diversity and future product diversity in the drug industry  |
| Authors: | | Cantner, Uwe Plotnikova, Tatiana |
| Issue Date: | | 2009 |
| Series/Report no.: | | Jena economic research papers 2009,031 |
| Abstract: | | This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the diversity of a firm's product portfolio. More specifically, we try to explain large firms' expansion into new product markets driven by the characteristics of their technological knowledge. Empirically, we study firms in the pharmaceutical and biotech industries, using relevant data on product development and technological knowledge. We find a positive relationship between the diversity of a firm's future product portfolio and the diversity of its stock of technological knowledge. This relationship becomes weaker when the breadth of technological knowledge increases. |
| Subjects: | | Product diversity technological diversity product relatedness technological relatedness coherence |
| JEL: | | O32 L25 L65 |
| Document Type: | | Working Paper |
| Appears in Collections: | | Jena Economic Research Papers, MPI für Ökonomik
|
| |
| | |
Download bibliographical data as:
BibTeX
|
| |
Share on:http://hdl.handle.net/10419/31772
|
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.
|